About Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits.
Variant Bio was founded in 2018 and is headquartered in Seattle, Washington.
Company details
Funding
Total raised
$130M
Last stage
Series B
Investors
Founders
Josh Wolfe
Co-founder and managing partner of Lux Capital, who seeded Variant Bio with initial funding in 2018 and co-founded the company alongside Kaja Wasik and Stephane Castel.
Kaja Wasik
PhD in Molecular Genetics from Cold Spring Harbor Laboratory. Previously co-founder and CSO at Gencove. Left Variant Bio CSO role to pursue new ventures including Echo Labs.
LinkedIn
Stephane Castel
PhD; completed postdoctoral research at the New York Genome Center and Columbia University studying molecular mechanisms underlying genetic associations to disease.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.